SSRIs: beware of interactions, comorbid conditions and overdose

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 858卷 / 1期
关键词：
Fluoxetine; Adverse Drug Reaction; Paroxetine; Sertraline; Selective Serotonin Reuptake Inhibitor;
D O I：
10.2165/00128415-200108580-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 8 条
  • [1] Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose
    Isbister, GK
    Bowe, SJ
    Dawson, A
    Whyte, IM
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2004, 42 (03): : 277 - 285
  • [2] Clinically significant drug interactions with SSRIs
    Reactions Weekly, 1998, 683 (1) : 2 - 2
  • [3] Be aware of interactions with SSRIs
    Reactions Weekly, 1997, 644 (1) : 2 - 2
  • [4] Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
    Mandrioli, R.
    Mercolini, L.
    Saracino, M. A.
    Raggi, M. A.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (12) : 1846 - 1863
  • [5] Comorbid epilepsy and depression-pharmacokinetic and pharmacodynamic drug interactions
    Miziak, Barbara
    Czuczwar, Stanislaw J.
    Pluta, Ryszard
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy
    Zaccara, Gaetano
    Lattanzi, Simona
    Russo, Emilio
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (05) : 595 - 609
  • [7] Premenstrual Dysphoric Disorder Without Comorbid Psychiatric Conditions: A Systematic Review of Therapeutic Options
    Sepede, Gianna
    Sarchione, Fabiola
    Matarazzo, Ilaria
    Di Giannantonio, Massimo
    Salerno, Rosa Maria
    CLINICAL NEUROPHARMACOLOGY, 2016, 39 (05) : 241 - 261
  • [8] Case report: Chronological symptom profile after cessation of overdose zolpidem in a patient with comorbid bipolar disorder-from anxiety, craving, paresthesia and influenza-like symptoms to seizures and hallucinations
    Mao, Zi-xin
    Yang, Xia
    Wang, Hui-yao
    Guo, Wan-jun
    FRONTIERS IN PSYCHIATRY, 2022, 13
1